openPR Logo
Press release

Intraosseous Infusion Devices Market Opportunity Analysis, 2018-2026

08-16-2018 01:03 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Intraosseous Infusion Devices Market Opportunity Analysis,

Intraosseous infusion is a procedure of injecting medicine or solutions into the human bone marrow to provide a continuous entry point in the systemic circulation. The technique is used when intravenous access is not available or when they are not possible and this is also a technique for vascular entry and are broadly applied for drug administration in adults and in children. The intraosseous devices are used majorly in trauma patients when intravenous access cannot be obtained. The places of insertion are sternum (FAST1), proximal and distal tibia and humerus EZ-IO. This devices are used for emergency recovery and are removed within 24 hours of insertion or after peripheral or central intravenous access has been achieved.

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/507

Several different technological types of intraosseous devices are battery-powered needles, manual IO needles, semi-automatic devices and impact driven devices. Intraosseous infusion devices are used in adult and pediatric patients. The procedure for insertion of intraosseous infusion devices is simple and can be inserted in proximal humerus, proximal tibia, and distal tibia. In the case of FAST1 it is specially designed to use when the traditional intravenous access fails. In FAST1 success rates (flow rates up to 125 mL/min) are higher than conventional intravenous infusion. Intraosseous infusion devices are generally used in the contraindications treatment such as factures, prosthetic joints, osteoporosis, and other bone abnormalities.

Rise in number of traumatic surgeries and increase in prevalence of cardiovascular disorders is expected to further bolster growth of the intraosseous infusion devices market

North America is expected to account for largest share in the global intraosseous infusion devices market due to the rise in emergency medical cases, increasing incidence of chronic diseases such as cardiovascular diseases, traumatic injuries, obesity and severe burns.

According to the National Trauma Institute (NTI), in the year 2014 the trauma injuries was accounted that around 41 million emergence department visits and 2.3 million hospital admission across the U.S. As per American College of Surgeons, around 833,311 trauma surgery cases found in the U.S. in 2013 out of that around 312,508 were females and 520,570 were males.

According to the World Health Organization (WHO), it was estimated that around 17.7 million people died from cardiovascular diseases (CVDs) in 2015, representing around 31% of global deaths. Among these deaths, around 7.4% were due to coronary heart disease and around 6.7 million fatalities were attributed to stroke. Factors influencing this disease rate was unhealthy diet, physical inactivity, tobacco consumption and alcohol consumption. As heart disease is one of the leading cause of death, as per data provided by Centers for Disease Control and Prevention (CDC), around 610,000 fatalities are reported in the U.S. due to heart disease each year. Furthermore, 365,000 fatalities were in the U.S. due to coronary heart disease around 365,000 people died in 2014.

As per American Heart and Stroke Association, incidence of heart attack in the U.S. was pegged at 58,000 in 2014, and in 2013 worldwide prevalence of stroke was around 25.7 million. This high number of lifestyle disease cases expected to drive the intraosseous infusion devices market in the near future.

Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/507

Intraosseous Infusion Devices Market by Key Players Includes:

PerSys Medical
Pyng Medical Corporation.
Aero Healthcare
Vidacare
Teleflex
implox Pty Ltd.
PAVmed
Biopsybell
Becton Dickinson Company / Carefusion Inc.
Cook Medical Inc.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intraosseous Infusion Devices Market Opportunity Analysis, 2018-2026 here

News-ID: 1182800 • Views:

More Releases from Coherent Market Insights

Global Antihistamine Drugs Market Expected to Expand at a Steady 2024-2031 | Bayer AG, Almirall  S.A, GlaxoSmithKline, Johnson and Johnson.
Global Antihistamine Drugs Market Expected to Expand at a Steady 2024-2031 | Bay …
Coherent Market Insights introduces new research on the Global Antihistamine Drugs Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also
Incretin Mimetics Market Future Business Opportunities 2024-2031 | GSK, Novo Nordisk, Lily, Haosoh, Sanofi, AstraZeneca, Pfizer Inc.
Incretin Mimetics Market Future Business Opportunities 2024-2031 | GSK, Novo Nor …
Coherent Market Insights introduces new research on the Incretin Mimetics Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also focuses
Skin Rash Treatment Market Huge Growth in Future Scope 2024-2031 | AbbVie, Amgen, Bristol Myers Squibb, Galderma, Johnson & Johnson.
Skin Rash Treatment Market Huge Growth in Future Scope 2024-2031 | AbbVie, Amgen …
Coherent Market Insights introduces new research on the Skin Rash Treatment Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also
Global Vitamin API Market Growth in Future Scope 2024-2031 | DSM, BASF, BOC Sciences, CSPC Pharmaceutical Group Limited.
Global Vitamin API Market Growth in Future Scope 2024-2031 | DSM, BASF, BOC Scie …
Coherent Market Insights introduces new research on the Global Vitamin API Market covering the micro level of analysis by competitors and key business segments (2024-2031). This report study encompasses a thorough examination of diverse segments, including opportunities, size, development, innovation, sales, and overall growth trajectory of major players. The research is carried out on primary and secondary statistical sources, providing a blend of qualitative and quantitative insights. The report also

All 5 Releases


More Releases for Intraosseous

Intraosseous Devices Market Growth, Trends, and Report 2026
Intraosseous Devices Market:Overview The rise in the number of emergency cases such as heart attack and trauma-related attacks is estimated to be a significant factor for the growth of the intraosseous devices market during the forecast period of 2018-2026. Intraosseous devices assure of safe, better, and a convenient way of administering fluids and medications to the patients via the bone marrow. Based on end-user, the intraosseous devices market can be classified
Intraosseous Infusion Device Market Challenges and New Trends
According to a new report published by Allied Market Research, titled, “Intraosseous Infusion Device Market by Product Type (FAST1 device, Dieckmann Modified Needle, BIG device, EZ-IO device, Jamshidi Needle, FASTx device, and NIO), by Technology (Battery Powered Driver, Manual IO Needles, and Impact Driven Devices), by Route of Administration (Distal Femur, Sternum, Distal & Proximal Tibia, Calcaneus, and Head of Humerus), by End User (Hospitals, Emergency Medical Services, Ambulatory Surgical
Intraosseous Devices Market Intelligence Report Offers Growth Prospects
Establishment of vascular access is required in case of medical emergency and life-threatening traumatic injuries for the delivery of medications and for fluid replacement, including crystalloids, blood, and blood products. The potential use of this technique called as, intraosseous infusion was established in 1920’s as a rapid, safe and effective method of vascular access through the bone marrow when intravenous attempt fails to establish vascular access. Historically intraosseous infusion (IO)
Global Intraosseous Device Industry Analysis Sales Market Report 2018
The Global Intraosseous Device Sales Market Report 2018 is in-depth study of overall Intraosseous Device market including introduction of product, definition, scope, Intraosseous Device global sale, and forecast up to 2025. The Intraosseous Device industry report clarifies the past experience and trends, on the basis of these past experiences, it offers the future prediction considering other factors influencing the growth rate. This worldwide report offers the detailed analysis of the important factors such as market dynamics (DROT), PEST,
Intraosseous Devices Market to Witness Widespread Expansion By 2026
Currently there are many intraosseous devices available in the market for the rapid administration of fluids and medications directly into the vascular systems. These devices are inserted directly into the medullary space of bone, and range from manually inserted spinal needles to the impact drivers and drill powered devices. The manually inserted needles have been approved in the U.S. since 1940’s. In addition site of insertion also plays an important
Intraosseous Infusion Devices Market
Intraosseous infusion is a procedure of injecting medicine or solutions into the human bone marrow to provide a continuous entry point in the systemic circulation. The technique is used when intravenous access is not available or when they are not possible and this is also a technique for vascular entry and are broadly applied for drug administration in adults and in children. The intraosseous devices are used majorly in trauma